COMMUNITY HEALTHCARE TRUST I (CHCT) Fundamental Analysis & Valuation
NYSE:CHCT • US20369C1062
Current stock price
16.15 USD
-0.01 (-0.06%)
At close:
16.15 USD
0 (0%)
After Hours:
This CHCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHCT Profitability Analysis
1.1 Basic Checks
- In the past year CHCT was profitable.
- In the past year CHCT had a positive cash flow from operations.
- CHCT had positive earnings in 4 of the past 5 years.
- Each year in the past 5 years CHCT had a positive operating cash flow.
1.2 Ratios
- CHCT has a Return On Assets (0.21%) which is comparable to the rest of the industry.
- CHCT's Return On Equity of 0.48% is in line compared to the rest of the industry. CHCT outperforms 43.09% of its industry peers.
- CHCT's Return On Invested Capital of 2.35% is in line compared to the rest of the industry. CHCT outperforms 43.90% of its industry peers.
- CHCT had an Average Return On Invested Capital over the past 3 years of 2.34%. This is in line with the industry average of 3.11%.
- The 3 year average ROIC (2.34%) for CHCT is below the current ROIC(2.35%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.21% | ||
| ROE | 0.48% | ||
| ROIC | 2.35% |
ROA(3y)0.05%
ROA(5y)1%
ROE(3y)0.07%
ROE(5y)1.69%
ROIC(3y)2.34%
ROIC(5y)2.72%
1.3 Margins
- CHCT has a Profit Margin (1.72%) which is comparable to the rest of the industry.
- CHCT's Profit Margin has declined in the last couple of years.
- CHCT has a Operating Margin (23.88%) which is in line with its industry peers.
- In the last couple of years the Operating Margin of CHCT has declined.
- CHCT has a Gross Margin of 80.51%. This is amongst the best in the industry. CHCT outperforms 81.30% of its industry peers.
- CHCT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.88% | ||
| PM (TTM) | 1.72% | ||
| GM | 80.51% |
OM growth 3Y-11.69%
OM growth 5Y-8.33%
PM growth 3Y-55.61%
PM growth 5Y-40.38%
GM growth 3Y-1%
GM growth 5Y-0.37%
2. CHCT Health Analysis
2.1 Basic Checks
- CHCT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, CHCT has more shares outstanding
- CHCT has more shares outstanding than it did 5 years ago.
- CHCT has a worse debt/assets ratio than last year.
2.2 Solvency
- CHCT has an Altman-Z score of 0.83. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of CHCT (0.83) is better than 67.48% of its industry peers.
- A Debt/Equity ratio of 1.25 is on the high side and indicates that CHCT has dependencies on debt financing.
- The Debt to Equity ratio of CHCT (1.25) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.83 |
ROIC/WACC0.36
WACC6.62%
2.3 Liquidity
- CHCT has a Current Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.47, CHCT is doing worse than 76.42% of the companies in the same industry.
- A Quick Ratio of 0.18 indicates that CHCT may have some problems paying its short term obligations.
- CHCT has a Quick ratio of 0.18. This is amonst the worse of the industry: CHCT underperforms 91.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.18 |
3. CHCT Growth Analysis
3.1 Past
- CHCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.43%, which is quite impressive.
- The earnings per share for CHCT have been decreasing by -14.76% on average. This is quite bad
- CHCT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.49%.
- Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 9.88% on average per year.
EPS 1Y (TTM)71.43%
EPS 3Y-24%
EPS 5Y-14.76%
EPS Q2Q%1275%
Revenue 1Y (TTM)-16.49%
Revenue growth 3Y7.45%
Revenue growth 5Y9.88%
Sales Q2Q%5.64%
3.2 Future
- CHCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.29% yearly.
- CHCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.55% yearly.
EPS Next Y33.17%
EPS Next 2Y29.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.37%
Revenue Next 2Y7.48%
Revenue Next 3Y10.05%
Revenue Next 5Y10.55%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. CHCT Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 44.86, the valuation of CHCT can be described as expensive.
- CHCT's Price/Earnings ratio is in line with the industry average.
- CHCT is valuated expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
- CHCT is valuated quite expensively with a Price/Forward Earnings ratio of 33.69.
- CHCT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 73.17% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of CHCT to the average of the S&P500 Index (23.84), we can say CHCT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.86 | ||
| Fwd PE | 33.69 |
4.2 Price Multiples
- CHCT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 60.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.71 |
4.3 Compensation for Growth
- CHCT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as CHCT's earnings are expected to grow with 29.29% in the coming years.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y29.29%
EPS Next 3YN/A
5. CHCT Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 11.73%, CHCT is a good candidate for dividend investing.
- CHCT's Dividend Yield is rather good when compared to the industry average which is at 7.24. CHCT pays more dividend than 96.75% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, CHCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.73% |
5.2 History
- The dividend of CHCT has a limited annual growth rate of 2.43%.
- CHCT has paid a dividend for at least 10 years, which is a reliable track record.
- CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.43%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
- 2580.24% of the earnings are spent on dividend by CHCT. This is not a sustainable payout ratio.
- The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP2580.24%
EPS Next 2Y29.29%
EPS Next 3YN/A
CHCT Fundamentals: All Metrics, Ratios and Statistics
16.15
-0.01 (-0.06%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17 2026-02-17/amc
Earnings (Next)04-27 2026-04-27/amc
Inst Owners79.27%
Inst Owner Change-5.72%
Ins Owners6.13%
Ins Owner Change2.5%
Market Cap461.41M
Revenue(TTM)121.19M
Net Income(TTM)2.08M
Analysts80
Price Target19.13 (18.45%)
Short Float %2.24%
Short Ratio2.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.73% |
Yearly Dividend1.89
Dividend Growth(5Y)2.43%
DP2580.24%
Div Incr Years9
Div Non Decr Years9
Ex-Date02-23 2026-02-23 (0.4775)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)163.48%
Min EPS beat(2)-63.24%
Max EPS beat(2)390.2%
EPS beat(4)1
Avg EPS beat(4)45.11%
Min EPS beat(4)-88.54%
Max EPS beat(4)390.2%
EPS beat(8)1
Avg EPS beat(8)-4.32%
EPS beat(12)2
Avg EPS beat(12)-25.93%
EPS beat(16)2
Avg EPS beat(16)-23.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-3.35%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.25%
Revenue beat(12)1
Avg Revenue beat(12)-2.86%
Revenue beat(16)1
Avg Revenue beat(16)-2.66%
PT rev (1m)2.74%
PT rev (3m)5.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.86 | ||
| Fwd PE | 33.69 | ||
| P/S | 3.81 | ||
| P/FCF | N/A | ||
| P/OCF | 8.18 | ||
| P/B | 1.07 | ||
| P/tB | 1.08 | ||
| EV/EBITDA | 13.71 |
EPS(TTM)0.36
EY2.23%
EPS(NY)0.48
Fwd EY2.97%
FCF(TTM)-1
FCFYN/A
OCF(TTM)1.98
OCFY12.23%
SpS4.24
BVpS15.03
TBVpS14.98
PEG (NY)1.35
PEG (5Y)N/A
Graham Number11.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.21% | ||
| ROE | 0.48% | ||
| ROCE | 2.98% | ||
| ROIC | 2.35% | ||
| ROICexc | 2.36% | ||
| ROICexgc | 2.39% | ||
| OM | 23.88% | ||
| PM (TTM) | 1.72% | ||
| GM | 80.51% | ||
| FCFM | N/A |
ROA(3y)0.05%
ROA(5y)1%
ROE(3y)0.07%
ROE(5y)1.69%
ROIC(3y)2.34%
ROIC(5y)2.72%
ROICexc(3y)2.35%
ROICexc(5y)2.74%
ROICexgc(3y)2.4%
ROICexgc(5y)2.8%
ROCE(3y)2.96%
ROCE(5y)3.45%
ROICexgc growth 3Y-9.81%
ROICexgc growth 5Y-6.84%
ROICexc growth 3Y-9.27%
ROICexc growth 5Y-6.96%
OM growth 3Y-11.69%
OM growth 5Y-8.33%
PM growth 3Y-55.61%
PM growth 5Y-40.38%
GM growth 3Y-1%
GM growth 5Y-0.37%
F-Score5
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.39 | ||
| Cap/Depr | 195.51% | ||
| Cap/Sales | 70.24% | ||
| Interest Coverage | 1.12 | ||
| Cash Conversion | 77.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.18 | ||
| Altman-Z | 0.83 |
F-Score5
WACC6.62%
ROIC/WACC0.36
Cap/Depr(3y)239.76%
Cap/Depr(5y)272.78%
Cap/Sales(3y)86.16%
Cap/Sales(5y)94.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.43%
EPS 3Y-24%
EPS 5Y-14.76%
EPS Q2Q%1275%
EPS Next Y33.17%
EPS Next 2Y29.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.49%
Revenue growth 3Y7.45%
Revenue growth 5Y9.88%
Sales Q2Q%5.64%
Revenue Next Year6.37%
Revenue Next 2Y7.48%
Revenue Next 3Y10.05%
Revenue Next 5Y10.55%
EBIT growth 1Y-27.37%
EBIT growth 3Y-5.11%
EBIT growth 5Y0.72%
EBIT Next Year263.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.16%
OCF growth 3Y-2.18%
OCF growth 5Y3.13%
COMMUNITY HEALTHCARE TRUST I / CHCT Fundamental Analysis FAQ
What is the fundamental rating for CHCT stock?
ChartMill assigns a fundamental rating of 4 / 10 to CHCT.
What is the valuation status for CHCT stock?
ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.
What is the profitability of CHCT stock?
COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CHCT stock?
The Price/Earnings (PE) ratio for COMMUNITY HEALTHCARE TRUST I (CHCT) is 44.86 and the Price/Book (PB) ratio is 1.07.
Can you provide the financial health for CHCT stock?
The financial health rating of COMMUNITY HEALTHCARE TRUST I (CHCT) is 1 / 10.